Clinical Research

Pediatric Ophthalmology and Strabismus

Besivance Study: Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children

Investigator: Suqin Guo, MD

Co-Investigators: Patrick DeRespinis, MD, Rudolph Wagner, MD

Condition: Congenital Nasolacrimal Duct Obstruction (NLDO) in Children

Status: Active Enrollment

The goal of the study is to evaluate the application of Besivance™ (besifloxacin ophthalmic suspension, 0.6%) to treat congenital nasolacrimal duct obstruction in children 1-12 months old. This investigator-initiated study is sponsored by a grant from Bausch and Lomb, Inc.

For more information, please contact: Suqin Guo, MD at (973)-972-2031, Amanda Ribeiro, RN at (973)-972-2074, or Kathryn Boschert, MS at (973)-972-8308. 

Management of Cutaneous Hemangioma in Children   

Investigator: Suqin Guo, MD

Co-Investigators:Nina Ni, Paul Langer, MD, Roger Turbin, MD, Rudoph Wagner, MD,

Condition:Cutaneous Hemangioma in Children

Status: Data Analysis

The purpose of this retrospective study is to examine the effectiveness of the use of topical corticosteroids, topical beta-blockers, or a combination of both to treat cutaneous hemangioma of the face and neck in the pediatric population.

For more information, please contact: Suqin Guo, MD at (973)-972-2031. 

Research Home